Bruush Oral Care Inc. (BRSHF)
USD 0.0
(100.0%)
USD 0.0
(100.0%)
| Breakdown | 2022 | 2021 | 2020 |
|---|---|---|---|
| Revenue | 2.63 Million | 901.16 Thousand | 207.4 Thousand |
| Cost of Revenue | 2.33 Million | 5.33 Million | 119 Thousand |
| Gross Profit | 292.91 Thousand | -4.43 Million | 88.39 Thousand |
| Operating Expenses | 1.81 Million | 3.53 Million | 1.32 Million |
| Selling, General and Administrative Expenses | 11.89 Million | 3.53 Million | 1.32 Million |
| Research and Development Expenses | 96.43 Thousand | - | - |
| Other Expenses | - | - | - |
| Cost and Expenses | 11.78 Million | 8.87 Million | 1.44 Million |
| Operating Income | -9.15 Million | -7.96 Million | -1.23 Million |
| Interest Expense | 3.84 Million | 18.13 Thousand | 15.4 Thousand |
| Income Tax Expense | - | - | - |
| Earnings before Tax | -8.76 Million | -8.89 Million | -1.37 Million |
| Net Income | -8.76 Million | -8.89 Million | -1.37 Million |
| Earnings Per Share Basic | -45.64 | -30.27 | -4.69 |
| Earnings Per Share Diluted | -45.64 | -30.27 | -4.69 |
| Weighted Average Shares Outstanding | 192.03 Thousand | 293.74 Thousand | 293.74 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 192.03 Thousand | 293.74 Thousand | 293.74 Thousand |
| Gross Margin | 0.11 | -4.92 | 0.43 |
| EBIT Margin | -1.86 | -8.84 | -5.95 |
| Profit Margin | -3.33 | -9.87 | -6.65 |
| EBITDA | -4.9 Million | -8.87 Million | -1.36 Million |
| Earnings Before Tax Margin | -3.48 | -8.84 | -5.95 |
| Breakdown | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q3 | 2020 FY | 2019 FY |
|---|---|---|---|---|---|---|
| Revenue | 325.53 Thousand | 2.63 Million | 789.67 Thousand | 730.95 Thousand | 901.16 Thousand | 207.4 Thousand |
| Cost of Revenue | 641.74 Thousand | 2.33 Million | 988.7 Thousand | 511.75 Thousand | 5.33 Million | 119 Thousand |
| Gross Profit | -316.21 Thousand | 292.91 Thousand | -199.02 Thousand | 219.19 Thousand | -4.43 Million | 88.39 Thousand |
| Operating Expenses | 1.4 Million | 9.44 Million | 5.14 Million | 1.02 Million | 3.53 Million | 1.32 Million |
| Selling, General and Administrative Expenses | 1.27 Million | - | 5.04 Million | 1.02 Million | - | - |
| Research and Development Expenses | 1500.00 | - | 96.43 Thousand | - | - | - |
| Other Expenses | -130.15 Thousand | -166.15 Thousand | - | - | - | - |
| Cost and Expenses | 2.04 Million | 11.78 Million | 6.12 Million | 1.53 Million | 8.87 Million | 1.44 Million |
| Operating Income | -1.72 Million | -9.15 Million | -5.34 Million | -806.89 Thousand | -7.96 Million | -1.23 Million |
| Interest Expense | 220.17 Thousand | 3.84 Million | - | 380.92 Thousand | 18.13 Thousand | 15.4 Thousand |
| Income Tax Expense | -2.00 | 2.00 | -5.00 | -3.00 | - | - |
| Earnings before Tax | -475.09 Thousand | -8.76 Million | -625.94 Thousand | -1.29 Million | -8.89 Million | -1.37 Million |
| Net Income | -475.09 Thousand | -8.76 Million | -625.94 Thousand | -1.29 Million | -8.89 Million | -1.37 Million |
| Earnings Per Share Basic | -0.95 | - | -1.92 | -8.29 | - | - |
| Earnings Per Share Diluted | -0.95 | - | -1.92 | -8.29 | - | - |
| Weighted Average Shares Outstanding | 498.72 Thousand | 192.03 Thousand | 326.03 Thousand | 156 Thousand | 293.74 Thousand | 293.74 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 498.72 Thousand | 192.03 Thousand | 326.03 Thousand | 156 Thousand | 293.74 Thousand | 293.74 Thousand |
| Gross Margin | -0.97 | 0.11 | -0.25 | 0.30 | -4.92 | 0.43 |
| EBIT Margin | -5.28 | - | -6.75 | -1.10 | - | - |
| Profit Margin | -1.46 | -3.33 | -0.79 | -1.77 | -9.87 | -6.65 |
| EBITDA | -1.71 Million | - | -5.33 Million | -804.02 Thousand | - | - |
| Earnings Before Tax Margin | -5.29 | -3.48 | -6.76 | -1.10 | -8.84 | -5.95 |
603039
DTC
GPJA
AOA
KMERF
RAIZ4